CCGB(SZ:300138) Xin Lang Cai Jing·2025-09-25 11:57Core Points - Senior management personnel of Morning Light Biotechnology Group Co., Ltd. plan to reduce their shareholdings, specifically Li Fengfei [1] Summary by Sections Reduction Plan Details - Li Fengfei holds 567,883 shares of Morning Light, accounting for 0.12% of the total share capital. The planned reduction involves selling 140,000 shares, representing 0.03% of the total share capital, between October 27, 2025, and January 26, 2026, through centralized bidding or block trading. The reason for the reduction is personal financial needs, with shares sourced from pre-IPO issuance and stock incentive plans. The selling price will be determined based on market conditions at the time of sale [2] Commitment and Compliance - During the IPO, Li Fengfei made a commitment to limit share transfers to no more than 25% of his total holdings annually while in office, and no transfers for six months post-departure. After six months, transfers are limited to 50% of total holdings within the following year. As of the announcement date, Li Fengfei has adhered to these commitments without violations. The planned reduction aligns with previously disclosed intentions and commitments, and there are no circumstances preventing the reduction as per the Shenzhen Stock Exchange regulations [3]